Skip to content
Clinical Trials – home
Turku University Hospital
Sponsor

Turku University Hospital

Finland Kiinamyllynkatu 4-8, 20520 Turku, Finland

About the sponsor

Clinical work includes aneurysmal subarachnoid hemorrhage requiring intensive care and ventilatory support, with interest in neuroprotection, brain injury, and neurological outcome after severe acute cerebral events.

  • Intensive care neuroprotection
  • Subarachnoid hemorrhage
  • Ventilatory care

Research activity also extends to recovery after critical illness, with attention to survival and functional outcomes in acute neurologic disease.

About Specializations

Turku University Hospital runs clinical trials in conditions such as Prostate cancer, Appendicitis, Bladder cancer, Gastrointestinal carcinoma, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

19 clinical trials

Study on the Impact of Cisplatin and Drug Combination on Speech and Cognition in Cancer Patients

Registered drugNo placebo
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:Capecitabine
  • Sponsor:Turku University Hospital

Prostate cancer

Recruiting

Study of 99mTc-MIP-1404 SPECT/CT imaging compared to standard imaging methods for detecting lymph node metastases in patients with prostate cancer

Registered drugNo placebo
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:Piflufolastat (18F)
  • Sponsor:Turku University Hospital

Study on the Effect of Degarelix on Prostate-Specific Membrane Antigen in Patients with Untreated Metastatic Prostate Cancer

Registered drugNo placebo
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:Degarelix
  • Sponsor:Turku University Hospital

Study on the Effectiveness of [18F]FAPI-74 PET/CT for Detecting Lymph Node Spread in Patients with Pancreatic Cancer

InvestigationalNo placebo
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:[Al[18F]F]Fapi-74
  • Sponsor:Turku University Hospital

Colon cancer

Recruiting

Study of 18F-FAPI-74 PET/CT Imaging for Detection of Lymph Node Metastases in Patients with Colon Cancer

InvestigationalNo placebo
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:[Al[18F]F]Fapi-74
  • Sponsor:Turku University Hospital

Bladder cancer

Recruiting

Study comparing BCG and combination of BCG with electromotive mitomycin-C treatment in patients with high-risk non-muscle-invasive bladder cancer

Registered drugNo placebo
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:Mitomycin
  • Sponsor:Turku University Hospital
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:Oxygen
  • Sponsor:Turku University Hospital

Prostate cancer+1

Recruiting

Study on How Degarelix and Drug Combination Affect Gut Health in Patients with Prostate Cancer or Benign Prostate Hyperplasia

Registered drugNo placebo
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:Degarelix
  • Sponsor:Turku University Hospital

Cardiac sarcoidosis+1

Not yet recruiting

Diagnostic PET Study of Al[18F]F-NOTA-folate in Patients with Suspected Cardiac Sarcoidosis or Infective Endocarditis

InvestigationalNo placebo
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Sponsor:Turku University Hospital

Non-small cell lung cancer

Not yet recruiting

Study of 18F-FAPI-74 PET/CT Imaging to Detect Cancer Spread in Patients with Non-Small Cell Lung Cancer

InvestigationalNo placebo
Countries:FinlandFinland
  • Participants:18–64 years
  • Substances:[Al[18F]F]Fapi-74
  • Sponsor:Turku University Hospital

Procedural pain+1

Not yet recruiting

Comparing ropivacaine and bupivacaine for pain relief after hip replacement surgery in patients with hip osteoarthritis

Registered drugNo placebo
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:Bupivacaine Hydrochloride
  • Sponsor:Turku University Hospital

Appendicitis

Not yet recruiting

Study Comparing Antibiotic Treatment with Placebo for Patients with Acute Appendicitis Using Ertapenem, Metronidazole, and Levofloxacin

Registered drug
Countries:FinlandFinland
  • Participants:18–64 years
  • Substances:Ertapenem
  • Sponsor:Turku University Hospital

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.